130 related articles for article (PubMed ID: 2224398)
1. Anti-RNP antibodies and their clinical significance.
Montecucco C
Br J Rheumatol; 1990 Oct; 29(5):322-4. PubMed ID: 2224398
[No Abstract] [Full Text] [Related]
2. [Value of the characterization of anti-ribonucleoproteins and anti-Sm antibodies by immunoblotting and immunoprecipitation in connectivitis].
Combe B; Lussiez V; Rucheton M; Graafland H; Brunel C; Sany J
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):47-9. PubMed ID: 3281242
[No Abstract] [Full Text] [Related]
3. [Characterization by immunoblotting (western blot) of anti-RNP antibodies in 36 connective tissue disease patients of whom 26 had mixed connective tissue disease. Comparison with 28 lupus patients with anti-Sm antibodies].
Meyer O; Kuntz D; Kahn MF; Bourgeois R; Haim T
Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):39-44. PubMed ID: 2727580
[No Abstract] [Full Text] [Related]
4. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
[TBL] [Abstract][Full Text] [Related]
6. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
7. Detection of anti-SSA antibodies by indirect immunofluorescence.
Bossuyt X; Frans J; Hendrickx A; Godefridis G; Westhovens R; Mariën G
Clin Chem; 2004 Dec; 50(12):2361-9. PubMed ID: 15472036
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
Lemmer JP; Curry NH; Mallory JH; Waller MV
J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.
Zouali M; Eyquem A
J Clin Immunol; 1984 May; 4(3):209-19. PubMed ID: 6610689
[TBL] [Abstract][Full Text] [Related]
10. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
[No Abstract] [Full Text] [Related]
11. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients.
Hoffman RW; Sharp GC; Irvin WS; Anderson SK; Hewett JE; Pandey JP
Arthritis Rheum; 1991 Apr; 34(4):453-8. PubMed ID: 1826425
[TBL] [Abstract][Full Text] [Related]
12. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
Benhamou CL; Amor B; Menkes CJ; Delbarre F
Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-Sm antibody in systemic lupus erythematosus & related disorders.
Singh RR; Malaviya AN; Kailash S; Varghese T
Indian J Med Res; 1991 Jun; 94():206-10. PubMed ID: 1834551
[TBL] [Abstract][Full Text] [Related]
14. [HLA-DR in patients with systemic lupus erythematosus with anti-ribonucleoprotein antibodies and in mixed connective tissue disease].
Balthazar PA; Gabriel Júnior A; de Oliveira DP; de Oliveira MA; Rosales T; Iglesias SS; Assad RL; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(6):249-53. PubMed ID: 3879739
[No Abstract] [Full Text] [Related]
15. Clinical significance of screening for antibody to ribonucleoprotein.
Small P; Barrett D; Champlin E
Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
17. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases.
Miyachi K; Tan EM
Arthritis Rheum; 1979 Jan; 22(1):87-93. PubMed ID: 103560
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy in mixed connective tissue disease: comparison with systemic lupus erythematosus.
Kaufman RL; Kitridou RC
J Rheumatol; 1982; 9(4):549-55. PubMed ID: 6182291
[TBL] [Abstract][Full Text] [Related]
19. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
Maddison PJ; Mogavero H; Reichlin M
J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
[TBL] [Abstract][Full Text] [Related]
20. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
